Our nanodroplet-based sonication reagents improve microbial lysis efficiency, particularly for resilient microbes, enhancing diagnostic accuracy for food safety. Tailored to bind specific microbes, they offer a significant improvement over conventional methods.
Our innovative nanodroplet-based sonication reagents are designed to enhance the efficiency of microbial lysis, particularly targeting resilient microbes such as Gram-positive bacteria, fungi, and mycobacterium. By increasing lysis efficiency, these reagents improve the accuracy of microbial diagnostic tests for food safety. The nanodroplets bind to microbes and leverage sonication to create localized shear forces, achieving superior lysis efficiency compared to traditional bead-beating and chemical approaches.
Key features:
This technology is currently at Technology Readiness Level 4, having been validated in various microbial species and showing significant improvements in lysis efficiency. Future validation will focus on optimizing the process for food pathogen testing, with a robust workflow expected within a year.
Triangle Biotechnology, Inc. is a life science company that develops innovative sonication reagents designed to streamline biological sample preparation. The company's core technology, Amplified Acoustic Mechanical Processing (AAMP), utilizes patented nanodroplet-based reagents that, when added to a sample and subjected to ultrasound, act as microscopic mechanical amplifiers. These reagents store and release controlled cavitation energy, facilitating more efficient, high-throughput, and consistent processing compared to conventional methods. By enhancing the delivery of mechanical force directly to the sample, the technology enables high-quality extraction of DNA, chromatin, and other biomolecules, even from challenging materials like formalin-fixed paraffin-embedded (FFPE) tissues.
This technology directly addresses critical bottlenecks in next-generation sequencing (NGS), epigenetic assays, and clinical diagnostics, where sample preparation is often a slow, inconsistent, or expensive hurdle. By significantly increasing yields and processing speed while reducing required starting material, Triangle Biotechnology’s solutions enable researchers and clinicians to obtain high-quality data more reliably and cost-effectively. The company collaborates with researchers to apply these tools across various applications, including microbial enrichment for pathogen characterization and streamlined NGS workflows, helping to accelerate personalized medicine and therapeutic research.